EUVIMEDEUVIMED entdecken
Crossref

Harnessing Membrane-Targeting Photosensitizers to Evoke Ferroptosis and Pyroptosis Dual-Modal Cell Death for Antitumor Therapy

Ying Yin, Xiang Cheng, Duoyang Fan, Yanpeng Fang, Haohan Li, Xingru Zhou, Hongqi Guo, Wenbin Zeng iD, Fei Chen iD

Molecular Pharmaceutics · 2025

DOI: 10.1021/acs.molpharmaceut.5c01042 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2025. Verfasst von Ying Yin und 8 weiteren Autor:innen. Beteiligte Einrichtung: Xiangya School of Pharmaceutical Sciences, Central South University, Changsha 410013, China. Hauptthemen laut MEDLINE: Pyroptosis, Photosensitizing Agents, Ferroptosis, Photochemotherapy. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: Natural Science Foundation of Hunan Province, Scientific Research Foundation of Hunan Provincial Education Department, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Photodynamic therapy (PDT), a noninvasive and spatiotemporally controlled cancer treatment, often suffers from the mitochondrial or lysosomal accumulation of conventional photosensitizers (PSs), primarily triggering apoptosis and limiting efficacy against apoptosis-resistant tumors. Targeting the plasma membrane offers a promising, yet less explored, strategy to induce immunogenic cell death pathways like ferroptosis and pyroptosis, which can overcome therapeutic resistance. However, PSs capable of simultaneously targeting the plasma membrane and activating both ferroptosis and pyroptosis are scarce. Here, we present a simple and rational π-bridge engineering strategy to develop multifunctional membrane-anchored PSs. Among our synthesized compounds, TDTP exhibits strong near-infrared (NIR) fluorescence, distinct aggregation-induced emission (AIE) characteristics, superior reactive oxygen species (ROS) generation, and precise plasma membrane localization. Upon light activation, TDTP induces synergistic ferroptotic-pyroptotic cell death, leading to highly efficient tumor ablation at nanomolar concentrations (IC50 = 26.07 nM). In vivo studies demonstrate that TDTP enables high-contrast NIR imaging and substantially inhibits tumor growth under image-guided PDT. This work highlights a facile yet powerful strategy for constructing membrane-specific PSs and introduces a rare class of theranostic agents capable of inducing dual cell death pathways.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PyroptosisPhotosensitizing AgentsFerroptosisPhotochemotherapyCell MembraneNeoplasmsAntineoplastic AgentsHumansAnimalsMiceReactive Oxygen SpeciesCell Line, TumorApoptosisMice, Inbred BALB CCell Death

Stichwörter der Autor:innen

antitumor therapyferroptosismembrane-anchoredphotodynamic therapypyroptosis

Substanzen

Photosensitizing AgentsReactive Oxygen SpeciesAntineoplastic Agents

Autor:innen und Institutionen

  • Xiangya School of Pharmaceutical Sciences, Central South University, Changsha 410013, China.

ORCID-Profile: Wenbin Zeng, Fei Chen

Förderung

  • Natural Science Foundation of Hunan Province
  • Scientific Research Foundation of Hunan Provincial Education Department
  • National Natural Science Foundation of China

Zitieren

APA

Yin, Y., Cheng, X., Fan, D., Fang, Y., Li, H., Zhou, X., Guo, H., Zeng, W., & Chen, F. (2025). Harnessing Membrane-Targeting Photosensitizers to Evoke Ferroptosis and Pyroptosis Dual-Modal Cell Death for Antitumor Therapy. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.5c01042

Vancouver

Yin Y, Cheng X, Fan D, Fang Y, Li H, Zhou X, et al. Harnessing Membrane-Targeting Photosensitizers to Evoke Ferroptosis and Pyroptosis Dual-Modal Cell Death for Antitumor Therapy. Molecular Pharmaceutics. 2025. doi:10.1021/acs.molpharmaceut.5c01042

BibTeX
@article{Yin2025,
  author = {Yin, Ying and Cheng, Xiang and Fan, Duoyang and Fang, Yanpeng and Li, Haohan and Zhou, Xingru and Guo, Hongqi and Zeng, Wenbin and Chen, Fei},
  title = {Harnessing Membrane-Targeting Photosensitizers to Evoke Ferroptosis and Pyroptosis Dual-Modal Cell Death for Antitumor Therapy},
  journal = {Molecular Pharmaceutics},
  year = {2025},
  doi = {10.1021/acs.molpharmaceut.5c01042}
}
Kostenlos starten →